Superoxide dismutase gene polymorphisms and functional activity in chronic obstructive pulmonary disease

Feng GUO,Jiu-long KUANG
DOI: https://doi.org/10.3760/cma.j.issn.1001-0939.2011.06.008
2011-01-01
Abstract:Objective To explore the association of genetic polymorphism of superoxide dismutase (SOD) and superoxide dismutase activity in chronic obstructive pulmonary disease. Methods A total of 114 patients with COPD (the COPD group) and 80 healthy volunteers (the control group) were enrolled in this study. Peripheral blood was taken and whole blood cell genomic DNA was extracted. The genetic polymorphisms of Mn-SOD (G5774A) and EC-SOD G (-4466)T genes were determined by DNA sequencing and polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP). Peripheral blood plasma was collected and the functional activity of SOD was determined by a SOD kit. Results The distribution of the Mn-SOD genotype frequencies (GG, AG, AA) between the patients [27.2% (31/114), 53.5% (61/114) and 19.3% (22/114)] and the controls [46.3% (37/80), 37.5% (30/80) and 16.2% (13/80)] were significantly different (χ2=7.681, P<0.05). The A allele gene frequencies of the patients (46.1%, 105/228) were significant higher than those of the controls (35.0%, 56/160), and subjects with the A allele gene of Mn-SOD were more likely to have COPD [OR=1.585, 95%CI (1.045-2.404), P<0.05]. The AA and AG genotypes of Mn-SOD were correlated with the most severe COPD (χ2=12.345, P<0.01). The distribution of the EC-SOD genotype frequencies (GG, GT, TT) was 76.3%(87/114), 22.8%(26/114), 0.9% (1/114) in the patients and 71.3% (57/80), 28.7% (23/80), 0% (0/80) in the controls. The allele gene frequencies of the EC-SOD (G, T) were 87.7% (200/228), 12.3% (28/228) in the patients and 85.6% (137/160), 14.4% (23/160) in the controls. There were no significant differences in the distribution of the different genotypes or allele gene frequencies between the patients and the controls in the EC-SOD genes (χ2=0.631, P>0.05; χ2=0.36, P>0.05). The SOD activity of COPD patients [(84±17) kU/L] was significant lower than that of the healthy controls [(109±15) kU/L]. Conclusions Mn-SOD(G5774A) genetic polymorphism is related to the development of COPD. The Mn-SOD 5774A allele gene may be one of the predisposing genes for COPD. The AA and AG genotypes of Mn-SOD were correlated with the most severy COPD. The decrease of blood plasma SOD activity in COPD patients indicates a dysfunction of the oxidant/antioxidant defense system in the disease.
What problem does this paper attempt to address?